Levels of brain-derived neurotrophic factor in patients with multiple sclerosis.
Yvonne NaegelinKatharina SaeuberliSabine SchaedelinHayley DingsdaleStefano MagonSergio BaranziniMichael AmannKatrin ParmarCharidimos TsagkasPasquale CalabreseIris Katharina PennerLudwig KapposYves-Alain BardePublished in: Annals of clinical and translational neurology (2020)
We conclude that while the use of comparatively large cohorts enables the detection of a significant difference in BDNF levels between pwMS and HC, the difference is small and unlikely to usefully inform decision-making processes at an individual patient level.